PANZARELLA, KIM MD
Dermatology · NPI 1871593244 · COLONIAL HEIGHTS, VA
PANZARELLA, KIM is a Dermatology in COLONIAL HEIGHTS, VA, a member of 1 medical group, who billed 36 distinct codes to Medicare Part B in 2024.
Groups: DERMATOLOGY ASSOCIATES OF RICHMOND PC (RICHMOND, VA)
Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒
Provider overview · all codes · CY2024
All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.
Procedures billed to Medicare Part B (2024)
Medicare Part B FFS · CY2024 · as published by CMS| Code | Description | Services | Beneficiary-episodes | Avg charge | Avg Medicare payment |
|---|---|---|---|---|---|
| 17003 | Destruction of precancer skin growth, 2-14 growths | premium | premium | premium | premium |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | premium | premium | premium | premium |
| 17000 | Destruction of precancer skin growth, 1 growth | premium | premium | premium | premium |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | premium | premium | premium | premium |
| 17110 | Destruction of skin growth, 1-14 growths | premium | premium | premium | premium |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | premium | premium | premium | premium |
| 11102 | Biopsy of related skin growth, first growth | premium | premium | premium | premium |
| 96372 | Injection of drug or substance under skin or into muscle | premium | premium | premium | premium |
| 17004 | Destruction of precancer skin growth, 15 or more growths | premium | premium | premium | premium |
| 11200 | Removal of skin tag, 1-15 skin tags | premium | premium | premium | premium |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | premium | premium | premium | premium |
| 99212 | Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more | premium | premium | premium | premium |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | premium | premium | premium | premium |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | premium | premium | premium | premium |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | premium | premium | premium | premium |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | premium | premium | premium | premium |
| 11900 | Injection into skin growth, 1-7 growths | premium | premium | premium | premium |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | premium | premium | premium | premium |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | premium | premium | premium | premium |
| 11103 | Biopsy of related skin growth, each additional growth | premium | premium | premium | premium |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | premium | premium | premium | premium |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | premium | premium | premium | premium |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | premium | premium | premium | premium |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | premium | premium | premium | premium |
| 29580 | Strapping, unna boot | premium | premium | premium | premium |
| 11306 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | premium | premium | premium | premium |
| 99203 | New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
| 11104 | Punch biopsy, first skin growth | premium | premium | premium | premium |
| Q0112 | All potassium hydroxide (koh) preparations | premium | premium | premium | premium |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | premium | premium | premium | premium |
| 17111 | Destruction of skin growth, 15 or more growths | premium | premium | premium | premium |
| 17260 | Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less | premium | premium | premium | premium |
| 11305 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | premium | premium | premium | premium |
| 17280 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | premium | premium | premium | premium |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | premium | premium | premium | premium |
These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.